Pfizer’s $15 Billion Opportunity

Pfizer is considering selling its consumer healthcare business. Would Advil, Chapstick and Centrum vitamins fetch a price tag of $15 billion?  Industry Focus host Kristine Harjes analyzes the opportunity for Pfizer and its shareholders.  We also discuss her recent trip to Greece and it has her thinking about Square.  Plus, Kristine offers an earnings preview of Johnson & Johnson and advice for travelers to Greece. Thanks to Slack for supporting The Motley Fool.  Slack: Where work happens. Find out why at slack.com